Subscribe
shutterstock_1176271219_ivan_marc
Ivan Marc / Shutterstock.com
8 July 2019EuropeSarah Morgan

EMA settles Brexit dispute; issues drug shortages guidance

The European Medicines Agency (EMA) has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
No-deal Brexit: MHRA would take on EMA functions for UK
24 August 2018   The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.
Big Pharma
London loses EMA to Amsterdam
21 November 2017   The European Medicines Agency will relocate from its London, UK headquarters to Amsterdam, in the Netherlands.
Big Pharma
Pharma bodies sign NDAs with UK govt over no-deal Brexit plans
16 August 2019   Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
No-deal Brexit: MHRA would take on EMA functions for UK
24 August 2018   The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.
Big Pharma
London loses EMA to Amsterdam
21 November 2017   The European Medicines Agency will relocate from its London, UK headquarters to Amsterdam, in the Netherlands.
Big Pharma
Pharma bodies sign NDAs with UK govt over no-deal Brexit plans
16 August 2019   Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

More on this story

Big Pharma
No-deal Brexit: MHRA would take on EMA functions for UK
24 August 2018   The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.
Big Pharma
London loses EMA to Amsterdam
21 November 2017   The European Medicines Agency will relocate from its London, UK headquarters to Amsterdam, in the Netherlands.
Big Pharma
Pharma bodies sign NDAs with UK govt over no-deal Brexit plans
16 August 2019   Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

More features

President Trump 2.0: Five major areas to watch
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court